MEDLINE Journals

    Assessment of agitation in Alzheimer's disease: the agitated behavior in dementia scale. Alzheimer's Disease Cooperative Study.

    Authors

    Logsdon RG, Teri L, Weiner MF, et al. 

    Institution

    University of Washington, Seattle 98195-7263, USA.

    Source

    J Am Geriatr Soc 1999 Nov; 47(11) :1354-8.

    Abstract

    OBJECTIVES
    To develop and evaluate the psychometric properties of a new measure of agitation, the Agitated Behavior in Dementia scale (ABID). The ABID consists of 16 items designed specifically to evaluate frequency of and caregiver reaction to common agitated behaviors in community-residing dementia patients.
    DESIGN
    The ABID was administered at the baseline assessment of a multi-site controlled treatment study to reduce agitation in Alzheimer's Disease (AD). Reliability was assessed by evaluating internal consistency and test-retest correlations. Validity was assessed by examining correlations with other constructs, including demographics, cognitive status, and overall behavioral disturbance.
    SETTING
    Twenty-one sites across the US, comprising the Alzheimer's Disease Cooperative Study, contributed subjects to the investigation.
    PARTICIPANTS
    A total of 148 community-residing AD patients, living with a spouse or adult relative who acted as an informant. Mean age was 75 years, and mean Mini-Mental State Exam (MMSE) score was 13.
    MEASUREMENTS
    Cognitive status was assessed using the MMSE. Behavioral disturbance was assessed using the Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease, the Revised Memory and Behavior Problems Checklist, and the Cohen-Mansfield Agitation Inventory.
    RESULTS
    Reliability of the ABID was excellent, with internal consistency of 0.70 and test-retest reliability of 0.60 to 0.73. Validity was confirmed by correlations with related measures and lack of correlation with unrelated constructs.
    CONCLUSIONS
    The ABID is brief, easy to administer, and provides objectively anchored observations of problems. It is a promising measure for studies of community-residing AD patients.

    Mesh

    Aged
    Alzheimer Disease
    Behavior
    Caregivers
    Cognition
    Dementia
    Demography
    Female
    Geriatric Assessment
    Humans
    Interpersonal Relations
    Male
    Psychometrics
    Psychomotor Agitation
    Reproducibility of Results
    Stress, Psychological

    Language

    eng

    Pub Type(s)

    Clinical Trial Controlled Clinical Trial Journal Article Multicenter Study Research Support, U.S. Gov't, P.H.S.

    PubMed ID

    10573447

    Content Manager
    Related Content

    Reliability and validity of the Japanese version of the Agitated Behaviour in Dementia Scale in Alzheimer's disease: three dimensions of agitated behaviour in dementia.

    Performance-Based instrument to assess functional capacity in dementia: The Texas Functional Living Scale.

    Assessing patterns of agitation in Alzheimer's disease patients with the Cohen-Mansfield Agitation Inventory. The Alzheimer's Disease Cooperative Study.

    A comparison of the Cohen-Mansfield agitation inventory with the CERAD behavioral rating scale for dementia in community-dwelling persons with Alzheimer's disease.

    Agitated behaviours among the institutionalized elderly with dementia: validation of the Korean version of the Cohen-Mansfield Agitation Inventory.

    The Empirical Behavioral Pathology in Alzheimer's Disease (E-BEHAVE-AD) Rating Scale.

    The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease.

    Quantifying behavioral disturbance in Alzheimer's disease patients.